Stem cells - The Master Cells of Human Body

by Melvin Ngiam

The Stem cells are predominantly called the "master cells" of the human body because of their ability to create all other tissues, organs, and systems in the body. The stem cells are the building blocks of your blood and immune system. They are the factory of the blood system and continually make new copies of themselves and produce cells that make every other type of blood --Red blood Cells, White Blood Cells and Platelets. There are basically three sources where stem cells can be easily found .
1) Bone Marrow
2) Peripheral Blood and
3) Umbilical Cord Blood
Various researches done in this field suggest that stem cells obtained from cord blood are relatively more advantages over those retrieved from bone marrow or peripheral blood because they are immunologic ally "younger" and appear to be more versatile. They also demonstrate an important characteristic with embryonic stem cells and are able to differentiate into nearly all cell types in the body. Secondly it is easy to get stem cells from cord blood because they are readily obtained from the placenta at the time of delivery. Harvesting stem cells from bone marrow requires a surgical procedure, performed under general anesthesia and can cause post-operative pain or pose a small risk to the donor.
The promise of using stem cells for medical treatments have been the focus of researches various projects that are showing encouraging results.
  • Cord blood stem cells help in the treatment of diseases such as Alzheimer's and Parkinson's.
  • They have also proven their ability in the treatments for heart disease, allowing patients to essentially "grow their own bypass."
  • Stem cells have the potential to help cure many life-threatening ailments like leukemia, non-Hodgkin's lymphoma, anemia, inherited disorders and all other deficiencies of the immune system.
  • Lifestyle diseases such as diabetes, liver disorders and heart ailments can also be treated with stem cells.
On the other hand a wider range of recipients can benefit from cord blood stem cells. These can be stored and transplanted back into the donor, to a family member or to an unrelated recipient. For a bone marrow transplantation, there must be a nearly perfect match of certain tissue proteins between the donor and the recipient. When stem cells from cord blood are used, the donor cells appear more likely to "take" or engraft, even when there are partial tissue mismatches.
Certain complications like graft versus host disease (GVHD), in which donor cells can attack the recipient's tissues, are less likely to occur with cord blood than with bone marrow. This may be because cord blood has a muted immune system and certain cells, usually active in an immune reaction, are not yet educated to attack the recipient. A research done in this field revealed that children who received a cord blood transplant from a closely matched sibling were 59 percent less likely to develop GVHD than children who received a bone marrow transplant from a closely matched sibling.
Cord blood also is less likely to contain certain infectious agents, like some viruses, that can pose a risk to transplant recipients .In addition, cord blood may have a greater ability to generate new blood cells than bone marrow. Ounce for ounce, there are nearly 10 times as many blood-producing cells in cord blood. This fact suggests that a smaller number of cord blood cells are needed for a successful transplantation.
With the rapid advancement in Medical Science there has also been a corresponding development in the number of preserved cord blood units being used in regenerative medicine applications. If expectant parents store their baby's cord blood in a family bank, the stem cells are immediately available for use in medical treatments, including future therapies to repair or replace damaged heart tissues. As a result, an infant's cord blood could prove to be a life-saving treatment option if that child is born with a congenital heart defect, or later in life following a sudden and serious heart attack. In regenerative medicine, the latest scientific evidence suggests that using one's own stem cells likely delivers more favorable outcomes.


Information on Infectious Endocarditis

by Alicia Stock

Infectious Endocarditis is an illness of the lining of the heart chambers and heart valves, result by bacteria, fungi, or other infectious agents. In several congenital cardiac diseases, infection can also happen in the lining of the arteries that come out of the heart. Infectious endocarditis may arise in a person of any age. The prevalence of infective endocarditis is between 1.7 and 4 per 100,000 persons, most commonly affecting men in their fifties. There are two forms of infective endocarditis. One form, called acute infective endocarditis, develops suddenly and may become life threatening within days.
The other type, called subacute infective endocarditis or subacute bacterial endocarditis, develops slowly and faintly over a period of weeks to several months. Bacteria may be introduced into the bloodstream. These organisms can then lodge on heart valves and infect the endocardium. Abnormal, damaged, or artificial valves are more susceptible to infection than normal valves. The bacteria that cause subacute bacterial endocarditis nearly always infect abnormal, damaged, or artificial valves. However, normal valves can be infected by some aggressive bacteria, especially if many bacteria are present.
The signs and symptoms of infective endocarditis depend on the causative organism. Symptoms of endocarditis may grow gradually or suddenly. Symptoms may involve fever, tiredness, weight loss, new rashes, headaches, backaches, joint pains, and confusion. A new heart murmur as well as new skin, fingernail, and retinal lesions are typical physical findings in endocarditis. Risk factors for children and young adults include birth defects, particularly a defect that allows blood to leak from one part of the heart to another. One risk factor for older people is degeneration of the valves or calcium deposits in the mitral valve or in the aortic valve.
Infective Endocarditis affects twice as many men as women of all ages but 8 times as lots of older men as older women. Damage to the heart by rheumatic fever as a child (rheumatic heart sickness) is also a risk issue. Infective endocarditis is treated with antibiotics and with surgery in some situations. The chosen antibiotic must be specific for the organism causing the condition. Treatment is generally given for 4-6 weeks, depending on the definite type of bacteria. Surgery may be required to replace damage heart valves. Good oral and dental hygiene is also thought to be important.